Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

A 14-year-old boy was diagnosed with a rare hair condition that may lead to hair thinning and has no known effective treatments.

Androgens shorten hair growth phases, causing finer hair and more severe hair loss in men.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Changing hair follicle identity could potentially reverse balding.

Finasteride reduces hair follicle cell death in androgenetic alopecia.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Topical finasteride promotes hair growth with minimal side effects but needs more research for women and optimal use.

Finasteride and minoxidil are the main effective treatments for hair loss from androgenetic alopecia.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

A new method was developed to purify finasteride for better medical use.

Higher DHT in male baldness may protect against prostate cancer.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

Finasteride works better for hair loss in patients 26 or younger.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Higher androgen levels do not cause baldness in men.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

The effects of estrogen on human scalp hair growth are unclear and need more research.

New methods reliably assess hair regrowth and scalp health in hair loss patients.